Announcements
-
2022 / 04 / 20PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY
-
2022 / 04 / 06MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2022
-
2022 / 03 / 30ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021
-
2022 / 03 / 14VOLUNTARY ANNOUNCEMENT - The first enrollment for confirmatory clinical trials of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System had been completed in China
-
2022 / 03 / 11NOTICE OF BOARD MEETING
-
2022 / 03 / 04DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF PRINCIPAL-PROTECTED STRUCTURED DEPOSIT
-
2022 / 03 / 04MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2022
-
2022 / 03 / 03ADOPTION OF THE 2022 SHARE AWARD SCHEME
-
2022 / 02 / 08MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2022
-
2022 / 01 / 06MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2021
